Evidence map›Paper›PMID 34212779›Full record

ArticleJournal of the American Heart Association2021

Targeting Hypertension Screening in Low- and Middle-Income Countries: A Cross-Sectional Analysis of 1.2 Million Adults in 56 Countries.

Tabea K Kirschbaum, Michaela Theilmann, Nikkil Sudharsanan, Jennifer Manne-Goehler, Julia M Lemp, Jan-Walter De Neve, Maja E Marcus, Cara Ebert, Simiao Chen, Krishna K Aryal and 19 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Tabea K KirschbaumHeidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.
Michaela TheilmannHeidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.
Nikkil SudharsananHeidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.
Jennifer Manne-GoehlerDivision of Infectious Diseases Massachusetts General HospitalHarvard Medical School Boston MA.
Julia M LempHeidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.
Jan-Walter De NeveHeidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.
Maja E MarcusDepartment of Economics and Centre for Modern Indian Studies University of Goettingen Germany.
Cara EbertRWI-Leibniz Institute for Economic Research Berlin Germany.
Simiao ChenHeidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.
Krishna K AryalMonitoring Evaluation and Operational Research Project Abt Associates Kathmandu Nepal.
Silver K BahendekaSaint Francis Hospital, Nsambya Kampala Uganda.
Bolormaa NorovNational Center for Public Health Ulaanbaatar Mongolia.
Albertino DamascenoFaculty of Medicine Eduardo Mondlane University Maputo Mozambique.
Maria DorobantuCardiology Department Emergency Hospital of Bucharest Romania.
Farshad FarzadfarNon-Communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
Nima FattahiNon-Communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
Mongal S GurungHealth Research and Epidemiology Unit Policy and Planning Division Ministry of Health Thimphu Bhutan.
David GuwatuddeDepartment of Epidemiology and Biostatistics School of Public Health Makerere University Kampala Uganda.
Demetre LabadariosFaculty of Medicine and Health Sciences Stellenbosch University Stellenbosch South Africa.
Nuno LunetDepartamento de Ciências da Saúde Pública e Forenses e Educação Médica Faculdade de Medicina da Universidade do Porto Porto Portugal.
Elham RayzanNon-Communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
Sahar Saeedi MoghaddamEndocrinology and Metabolism Research Center Endocrinology and Metabolism Clinical Sciences Institute Tehran University of Medical Sciences Tehran Iran.
Jacqui WebsterThe George Institute for Global HealthUniversity of New South Wales Sydney Australia.
Justine I DaviesInstitute of Applied Health Research University of Birmingham United Kingdom.
Rifat AtunDepartment of Global Health and Population Harvard T.H. Chan School of Public Health Boston MA.
Sebastian VollmerDepartment of Economics and Centre for Modern Indian Studies University of Goettingen Germany.
Till BärnighausenHeidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.
Lindsay M JaacksDepartment of Global Health and Population Harvard T.H. Chan School of Public Health Boston MA.
Pascal GeldsetzerHeidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.

Funding

Institutional Career Development Core (KL2)KL2TR003143 · NCATS · STANFORD UNIVERSITY · PI ASCH, STEVEN M. · 2019 to 2023
$8.7M
NCATS NIH HHS KL2 TR003143
6 · The paper itself

Abstract

Background As screening programs in low- and middle-income countries (LMICs) often do not have the resources to screen the entire population, there is frequently a need to target such efforts to easily identifiable priority groups. This study aimed to determine (1) how hypertension prevalence in LMICs varies by age, sex, body mass index, and smoking status, and (2) the ability of different combinations of these variables to accurately predict hypertension. Methods and Results We analyzed individual-level, nationally representative data from 1 170 629 participants in 56 LMICs, of whom 220 636 (18.8%) had hypertension. Hypertension was defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or reporting to be taking blood pressure-lowering medication. The shape of the positive association of hypertension with age and body mass index varied across world regions. We used logistic regression and random forest models to compute the area under the receiver operating characteristic curve in each country for different combinations of age, body mass index, sex, and smoking status. The area under the receiver operating characteristic curve for the model with all 4 predictors ranged from 0.64 to 0.85 between countries, with a country-level mean of 0.76 across LMICs globally. The mean absolute increase in the area under the receiver operating characteristic curve from the model including only age to the model including all 4 predictors was 0.05. Conclusions Adding body mass index, sex, and smoking status to age led to only a minor increase in the ability to distinguish between adults with and without hypertension compared with using age alone. Hypertension screening programs in LMICs could use age as the primary variable to target their efforts.

Indexed as

Blood PressureDeveloping CountriesDiagnostic Screening ProgramsAdultAge FactorsBody Mass IndexCross-Sectional StudiesFemaleHealth SurveysHumansHypertensionIncomeMaleMiddle AgedObesityPredictive Value of Testscardiovascular diseaseepidemiologylow‐ and middle‐income countriesnoncommunicable diseasesprevention

Identifiers

PMID34212779
PMCPMC8403275

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.